Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,631.65
6.25 (0.38%)
BSENSE

Dec 19

BSE+NSE Vol: 5.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,631.65",
    "chg": 6.25,
    "chgp": "0.38%",
    "dir": 1,
    "prev_price": "1,625.40",
    "mcapval": "772.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE194R01017",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "5.26 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Technical Momentum Shift Signals Mixed Market Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-sees-mixed-technical-signals-amid-price-momentum-shift-3761976",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_technicaldot_3761976.png",
        "date": "2025-12-18 08:13:09",
        "description": "Fredun Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a nuanced market assessment amid a backdrop of strong long-term returns. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, with key technical indicators presenting a mixed picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Fredun Pharmaceuticals Shows Bullish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-technical-momentum-shifts-signal-bullish-outlook-3760770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_technicaldot_3760770.png",
        "date": "2025-12-17 08:14:09",
        "description": "Fredun Pharmaceuticals has exhibited a notable shift in price momentum, reflecting a bullish technical stance supported by key indicators such as MACD, moving averages, and Bollinger Bands. This development comes amid a broader market context where the stock’s performance continues to outpace benchmark indices, signalling renewed investor interest in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Fredun Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fredun-pharma-fallingrising-3760530",
        "imagepath": "",
        "date": "2025-12-17 01:12:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Fredun Pharmaceuticals has demonstrated remarkable resilience and growth over the past year, with a one-year return of 133.9%, significantly outperforming the Sensex’s modest 3.6% gain during the same period. Year-to-date, the stock has surged by 136.5%, dwarfing the benchmark’s 8.4% rise. Even over a five-year horizon, Fredun’s returns of 476.3% far exceed the Sensex’s 81.5%, underscoring its strong long-term performance within the pharmaceutical sector.</p>\n<p>Despite a slight one-month dip of 2.5%, the stock’s weekly performance remains positive at +0.3%, marginally ahead of the Sensex’s 0.02% gain. This recent uptick suggests renewed investor confidence after a brief consolidation phase.</p>\n<p><strong>Technical Factors Supporting ..."
      },
      {
        "title": "Fredun Pharmaceuticals Sees Shift in Technical Momentum Amid Strong Year-to-Date Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-sees-technical-momentum-shift-amid-strong-year-to-date-gains-3759521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_technicaldot_3759521.png",
        "date": "2025-12-16 08:16:10",
        "description": "Fredun Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum alongside robust year-to-date returns. Recent market data reveals evolving signals from key technical indicators, suggesting a nuanced change in price dynamics as the stock navigates current market conditions."
      },
      {
        "title": "Fredun Pharmaceuticals Hits New 52-Week High of Rs.1999",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-hits-new-52-week-high-at-rs-1999-3741468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_priceRelatedfactors_3741468.png",
        "date": "2025-12-02 10:06:25",
        "description": "Fredun Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.1999, marking a notable moment in the stock's performance within the Pharmaceuticals & Biotechnology sector. This achievement reflects sustained momentum driven by consistent gains and robust financial metrics over recent periods."
      },
      {
        "title": "Fredun Pharmaceuticals Hits New 52-Week High at Rs.1999",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-hits-new-52-week-high-at-rs-1999-3741467",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_priceRelatedfactors_3741467.png",
        "date": "2025-12-02 10:06:23",
        "description": "Fredun Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.1999, marking a notable achievement in its stock performance amid a challenging market environment."
      },
      {
        "title": "Fredun Pharmaceuticals Hits New 52-Week High of Rs.1999",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-hits-new-52-week-high-at-rs-1999-3741465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_priceRelatedfactors_3741465.png",
        "date": "2025-12-02 10:06:20",
        "description": "Fredun Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.1999, marking a notable moment in the stock's performance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Fredun Pharmaceuticals Hits All-Time High at Rs.1999, Marking a Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-stock-hits-all-time-high-at-rs-1999-3740936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_priceRelatedfactors_3740936.png",
        "date": "2025-12-02 09:34:18",
        "description": "Fredun Pharmaceuticals has reached a new all-time high of Rs.1999, reflecting a remarkable phase of sustained growth and strong market performance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Fredun Pharmaceuticals Hits New 52-Week High of Rs.1979.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-hits-new-52-week-high-at-rs-197995-3738539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FredunPharmaceu_priceRelatedfactors_3738539.png",
        "date": "2025-12-01 11:26:11",
        "description": "Fredun Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.1979.95, marking a notable moment in the company’s stock performance within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 208,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie",
      "datetime": "18-Dec-2025",
      "details": "Corrigendum through General Announcement regarding disclosure of Pre-Preferential Shareholding of Proposed Allottees Ultimate Beneficial Owners (UBOs) Revised Issue Size of Proposed Preferential Allotment Revised List of Allottes and Bifurcation and Brief description of the object of the issue in connection with the Extra-Ordinary General Meeting (EGM) held on October 22 2025.",
      "source": "BSE"
    },
    {
      "caption": "Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie",
      "datetime": "18-Dec-2025",
      "details": "Corrigendum through General Announcement regarding disclosure of Pre-Preferential shareholding of Proposed allottees Ultimate Beneficial Owners (UBOs) Revised issue size of Proposed Preferential allotment revised list of allottees bifurcation and brief description of the object of the issue and post shareholding pattern in connection with the Extra-Ordinary General Meeting (EGM) held on October 22 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Outcome Of Analysts/Investors Meeting Under The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015",
      "datetime": "17-Dec-2025",
      "details": "Outcome of Analyst/Investors meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Fredun Pharma falling/rising?

2025-12-17 01:12:35

Recent Price Movement and Market Context

Fredun Pharmaceuticals has demonstrated remarkable resilience and growth over the past year, with a one-year return of 133.9%, significantly outperforming the Sensex’s modest 3.6% gain during the same period. Year-to-date, the stock has surged by 136.5%, dwarfing the benchmark’s 8.4% rise. Even over a five-year horizon, Fredun’s returns of 476.3% far exceed the Sensex’s 81.5%, underscoring its strong long-term performance within the pharmaceutical sector.

Despite a slight one-month dip of 2.5%, the stock’s weekly performance remains positive at +0.3%, marginally ahead of the Sensex’s 0.02% gain. This recent uptick suggests renewed investor confidence after a brief consolidation phase.

Technical Factors Supporting ...

Read More
stock-recommendationAnnouncement

Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie

18-Dec-2025 | Source : BSE

Corrigendum through General Announcement regarding disclosure of Pre-Preferential Shareholding of Proposed Allottees Ultimate Beneficial Owners (UBOs) Revised Issue Size of Proposed Preferential Allotment Revised List of Allottes and Bifurcation and Brief description of the object of the issue in connection with the Extra-Ordinary General Meeting (EGM) held on October 22 2025.

Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie

18-Dec-2025 | Source : BSE

Corrigendum through General Announcement regarding disclosure of Pre-Preferential shareholding of Proposed allottees Ultimate Beneficial Owners (UBOs) Revised issue size of Proposed Preferential allotment revised list of allottees bifurcation and brief description of the object of the issue and post shareholding pattern in connection with the Extra-Ordinary General Meeting (EGM) held on October 22 2025

Intimation Of Outcome Of Analysts/Investors Meeting Under The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015

17-Dec-2025 | Source : BSE

Outcome of Analyst/Investors meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available